Worth reading
44Recurring
Scored from 1 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
0
Shares (number of shares issued during the month covered)Wording
Definitive
How definitive the wording is.Details of issuance or disposal
Monthly exercise status of the Series 2 and Series 3 share acquisition rights issued through a third-party allotment (with conversion rights to share acquisition rights with an exercise-price adjustment feature)
発行・処分する株式数
Series 2 share acquisition rights: 0 shares delivered during the month covered; 450,000 unexercised shares remaining / Series 3 share acquisition rights: 0 shares delivered during the month covered; 450,000 unexercised shares remaining
発行済株式総数
Exercise ratio during the month covered: 0.00% for the Series 2 share acquisition rights; 0.00% for the Series 3 share acquisition rights
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
Series 2 share acquisition rights: ¥550; Series 3 share acquisition rights: ¥600. Conversion rights to share acquisition rights with an exercise-price adjustment feature exist, but the company has not resolved to exercise the conversion rights, so the exercise prices will not be adjusted.
Number of Stock Acquisition Rights
Series 2 share acquisition rights: the total number issued is stated as the denominator for the exercise ratio during the month covered, but the number of units is Not disclosed; 4,500 units unexercised / Series 3 share acquisition rights: the total number issued is stated as the denominator for the exercise ratio during the month covered, but the number of units is Not disclosed; 4,500 units unexercised
Procedures under the Corporate Code of Conduct
Regarding the exercise restrictions under Article 434 of the Tokyo Stock Exchange's Securities Listing Regulations and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments, the company has not resolved to exercise the conversion rights into share acquisition rights with an exercise-price adjustment feature. Accordingly, the exercise prices will not be adjusted, and there are no exercise restrictions under the above provisions.
Most recent equity financing
Series 2 and Series 3 share acquisition rights issued through a third-party allotment on 4 January 2024
| Item | Details |
|---|---|
| Type of issuance or disposal | Monthly exercise status of the Series 2 and Series 3 share acquisition rights issued through a third-party allotment (with conversion rights to share acquisition rights with an exercise-price adjustment feature) |
| Number of shares to be issued or disposed of | Series 2 share acquisition rights: 0 shares delivered during the month covered; 450,000 unexercised shares remaining / Series 3 share acquisition rights: 0 shares delivered during the month covered; 450,000 unexercised shares remaining |
| Dilution Rate | Exercise ratio during the month covered: 0.00% for the Series 2 share acquisition rights; 0.00% for the Series 3 share acquisition rights |
| Total number of issued shares | 21,618,800 shares (as of the end of the month preceding the reporting month) → Not disclosed |
| Exercise price | Series 2 share acquisition rights: ¥550; Series 3 share acquisition rights: ¥600. Conversion rights to share acquisition rights with an exercise-price adjustment feature exist, but the company has not resolved to exercise the conversion rights, so the exercise prices will not be adjusted. |
| Number of Stock Acquisition Rights | Series 2 share acquisition rights: the total number issued is stated as the denominator for the exercise ratio during the month covered, but the number of units is Not disclosed; 4,500 units unexercised / Series 3 share acquisition rights: the total number issued is stated as the denominator for the exercise ratio during the month covered, but the number of units is Not disclosed; 4,500 units unexercised |
| Procedures under the Corporate Code of Conduct | Regarding the exercise restrictions under Article 434 of the Tokyo Stock Exchange's Securities Listing Regulations and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments, the company has not resolved to exercise the conversion rights into share acquisition rights with an exercise-price adjustment feature. Accordingly, the exercise prices will not be adjusted, and there are no exercise restrictions under the above provisions. |
| Most recent equity financing | Series 2 and Series 3 share acquisition rights issued through a third-party allotment on 4 January 2024 |
Items this document does not state (20)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company has not resolved to convert the Series 2 and Series 3 share acquisition rights into share acquisition rights with an exercise-price adjustment feature, so the exercise prices will not be adjusted. There were also no exercises during the month covered.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.